Results 11 to 20 of about 6,699,838 (364)

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

open access: yesNew England Journal of Medicine, 2020
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic.
F. Polack   +28 more
semanticscholar   +1 more source

Self-Efficacy

open access: yesDefinitions, 2020
—This study determines the relationship between teachers’ self-efficacy and age, gender, and marital status among teachers at rural high schools in the free state.
S. Phipps, C. Davis
semanticscholar   +1 more source

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

open access: yesThe Lancet, 2020
Summary Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic.
M. Voysey   +499 more
semanticscholar   +1 more source

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

open access: yesNew England Journal of Medicine, 2020
Background Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion ...
L. Baden   +36 more
semanticscholar   +1 more source

Assessing students’ self-efficacy when solve mathematical problem based on gender

open access: yes, 2022
Self-efficacy, problem solving, and gender differences are aspects that many researchers concern to today. Therefore, the purpose of this study was to describe the profile of students’ self-efficacy in solving problems based on gender.
Syamsu Alam   +5 more
core   +1 more source

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

open access: yesNew England Journal of Medicine, 2021
Background The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein in a prefusion-stabilized conformation.
J. Sadoff   +29 more
semanticscholar   +1 more source

Roots and stems of Kadsura coccinea extract induced developmental toxicity in zebrafish embryos/larvae through apoptosis and oxidative stress

open access: yesPharmaceutical Biology, 2020
Context Although the roots and stems of Kadsura coccinea (Lem.) A. C. Smith. [Schisandraceae] are herbs and traditional foods in Li nationality, its toxicity remains unclear. Objective To study developmental toxicity of K.
Zhongshang Xia   +8 more
doaj   +1 more source

Physics Achievement Test Implies Students’ Self-Efficacy on Decision Making Process [PDF]

open access: yes, 2019
This research was conducted to provide a comprehensive description about how the results of the cognitive learning outcomes of the physics field were indirectly supported by self-efficacy in the decision making process of the beliefs of the chosen ...
Istirahayu, Iip   +3 more
core   +1 more source

Gnetum montanum extract induces apoptosis by inhibiting the activation of AKT in SW480 human colon cancer cells

open access: yesPharmaceutical Biology, 2022
Context Gnetum montanum Markgr. (Gnetaceae) is used to treat rheumatic arthralgia and bruises in the clinic.Objective To exam the activity and mechanism of G.
Xianglong Pan   +10 more
doaj   +1 more source

Coaching Efficacy: The Leadership Efficacy Model [PDF]

open access: yes, 2020
This chapter introduces the leadership efficacy model applied to sports coaching. It is proposed in the model that leadership efficacy depends on the congruence between the conceptual cycle of leadership and the practical cycle of leadership and also by considering the leadership styles assumed by coaches and the moderating influence of the antecedent ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy